Drug intelligence / Profile preview

naringin + sericin

Development stage
Preclinical
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Topical (investigational/preclinical)
01

Overview

Naringin + sericin is a combination of two natural compounds—naringin, a flavonoid glycoside derived from Citrus maxima (pomelo), and sericin, a protein extracted from the silk of Bombyx mori. This combination has demonstrated significant anti-inflammatory and immunomodulatory effects in preclinical studies. Specifically, it acts by downregulating the expression and production of key pro-inflammatory cytokines such as TNF-α, IL-6, IL-23, and IL-12p40 in human peripheral blood mononuclear cells (hPBMCs) from patients with psoriasis. The inhibitory effect on these cytokines is more potent when both agents are used together compared to either alone. The primary investigated indication is psoriasis; however, its mechanism suggests potential utility in other inflammation-associated diseases. The combination may be considered as an adjunct or complementary therapy alongside conventional treatments for inflammatory skin conditions[1][2].

02

Targets

IL12B (Interleukin-12/23 p40 subunit)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on naringin + sericin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on naringin + sericin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call